Received: from PA7P264CA0260.FRAP264.PROD.OUTLOOK.COM (2603:10a6:102:375::15) by DBBPR02MB10722.eurprd02.prod.outlook.com (2603:10a6:10:534::7) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.496.21; Mon, 12 Oct 2026 08:06:34 +0000 Received: from MI3PEPF00008492.eurprd03.prod.outlook.com (2603:10a6:102:375:cafe::92) by PA7P264CA0260.outlook.office365.com (2603:10a6:102:375::15) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.496.5 via Frontend Transport; Mon, 12 Oct 2026 08:06:34 +0000 Received: from westeu11-emailsignatures-cloud.codetwo.com (20.93.157.195) by MI3PEPF00008492.mail.protection.outlook.com (10.167.240.153) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.522.6 via Frontend Transport; Mon, 12 Oct 2026 08:06:33 +0000 Received: from DBBPR02MB10722.eurprd02.prod.outlook.com (2603:10a6:10:534::7) by VI1PR02MB5024.eurprd02.prod.outlook.com with HTTPS; Mon, 12 Oct 2026 08:06:46 +0000 Received: from DU0PR02MB8782.eurprd02.prod.outlook.com ([fe80::d:e804:c51c:2f37]) by DU0PR02MB8782.eurprd02.prod.outlook.com ([fe80::d:e804:c51c:2f37%5]) with mapi id 15.21.0496.018; Mon, 12 Oct 2026 08:06:12 +0000 Received: from DU0PR02MB8782.eurprd02.prod.outlook.com (2603:10a6:10:412::7) by VI1PR02MB6062.eurprd02.prod.outlook.com (2603:10a6:800:188::18) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.496.21; Mon, 12 Oct 2026 08:06:12 +0000 Received: from GV1PR07CU001.outbound.protection.outlook.com (40.93.214.97) by westeu11-emailsignatures-cloud.codetwo.com with CodeTwo SMTP Server (TLS12) via SMTP; Mon, 12 Oct 2026 08:06:32 +0000 From: "Janne Sepp - RA" To: "Liisbet Aland \(EE\)" References: In-Reply-To: Subject: Vs: Ravimituru andmed Date: Mon, 12 Oct 2026 11:06:12 +0300 Message-ID: MIME-Version: 1.0 Content-Type: multipart/mixed; boundary="----=_NextPart_000_0235_01DD5CA3.8EC8C590" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQJb98GQ23k0lLIq3L+hW7AyMX8OcQKoTB1G Authentication-Results: mx.microsoft.com 1; spf=pass (sender IP is 20.93.157.195) smtp.mailfrom=ravimiamet.ee; dkim=none (message not signed) header.d=none;dmarc=pass action=none header.from=ravimiamet.ee; X-MS-Exchange-Organization-ExpirationStartTime: 12 Oct 2026 08:06:33.3928 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Exchange-Organization-Network-Message-Id: 61d0ad62-3248-4d9f-3a85-08df2837bae7 X-EOPAttributedMessage: 0 X-MS-Exchange-Organization-MessageDirectionality: Originating X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: DU0PR02MB8782:EE_|VI1PR02MB6062:EE_|MI3PEPF00008492:EE_|DBBPR02MB10722:EE_|VI1PR02MB5024:EE_ X-MS-Exchange-Organization-AuthSource: DU0PR02MB8782.eurprd02.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Internal X-MS-Office365-Filtering-Correlation-Id: 61d0ad62-3248-4d9f-3a85-08df2837bae7 X-MS-Exchange-AtpMessageProperties: SA X-MS-Exchange-Organization-SCL: 1 X-Microsoft-Antispam: BCL:0;ARA:13230040|39142699007|366016|31052699007|6049299003|23010399003|35042699022|82310400026|56012099006|11063799006|261009223027099003|260925021311599003|260925021911599003|260925022911599003|10067099003|22082099003|55112099003|18002099003|13003099007|8096899003|41050700001; X-Forefront-Antispam-Report: CIP:20.93.157.195;CTRY:NL;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:westeu11-emailsignatures-cloud.codetwo.com;PTR:westeu11-emailsignatures-cloud.codetwo.com;CAT:NONE;SFS:(13230040)(39142699007)(366016)(31052699007)(6049299003)(23010399003)(35042699022)(82310400026)(56012099006)(11063799006)(261009223027099003)(260925021311599003)(260925021911599003)(260925022911599003)(10067099003)(22082099003)(55112099003)(18002099003)(13003099007)(8096899003)(41050700001);DIR:INT; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 12 Oct 2026 08:06:33.3263 (UTC) X-MS-Exchange-CrossTenant-Network-Message-Id: 61d0ad62-3248-4d9f-3a85-08df2837bae7 X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthSource: DU0PR02MB8782.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-FromEntityHeader: HybridOnPrem X-MS-Exchange-Transport-CrossTenantHeadersStamped: DBBPR02MB10722 X-MS-Exchange-Transport-CrossTenantHeadersStamped: VI1PR02MB6062 X-MS-Exchange-Transport-EndToEndLatency: 00:00:13.6441129 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0496.018 X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(425001)(930201)(20251009284)(140003); X-Microsoft-Antispam-Message-Info: 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 Content-Language: et x-ms-exchange-organization-originalclientipaddress: 195.50.223.125 x-ms-exchange-organization-originalserveripaddress: 10.167.240.153 received-spf: Pass (protection.outlook.com: domain of ravimiamet.ee designates 20.93.157.195 as permitted sender) receiver=protection.outlook.com; client-ip=20.93.157.195; helo=westeu11-emailsignatures-cloud.codetwo.com; pr=C X-OlkEid: 00000000354180B9476080459B05E1BF834B446F070034AD76187591974DBF6C4F76951C873A01000200000000002495DA25D80D98438130990BFAFE78050000000007ED000093ABDCC0992E37468CD9173EFEF99CD0 X-MS-Has-Attach: yes X-MS-TNEF-Correlator: X-Microsoft-Antispam-Untrusted: BCL:0;ARA:13230040|6049299003|23010399003|31052699007|39142699007|366016|10067099003|18002099003|55112099003|22082099003|260925021311599003|260925021911599003|260925022911599003|8096899003|4013099003|13003099007|11063799006|261009223027099003|56012099006|41050700001; X-Microsoft-Antispam-Message-Info-Original: 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 X-Forefront-Antispam-Report-Untrusted: CIP:255.255.255.255;CTRY:;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:DU0PR02MB8782.eurprd02.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(6049299003)(23010399003)(31052699007)(39142699007)(366016)(10067099003)(18002099003)(55112099003)(22082099003)(260925021311599003)(260925021911599003)(260925022911599003)(8096899003)(4013099003)(13003099007)(11063799006)(261009223027099003)(56012099006)(41050700001);DIR:INT; X-Exchange-RoutingPolicyChecked: eIr/0jpNLAnno3RVgz4SuOVZNYyvHDR7Y301fe5khwN+h6ETFCMDwAqTYXQTMdSFws27X1KxkDd/ltF1iUcc61CYGLpnF9iw/t7CZ57KIAVQ96EXiJNLeFEv6xSwxnvTsdEBmYqLPmHoa7JXPsVMxEI5rxjr4zjDbYcgGfh1autPzf8h76HSF7iycTU+wPAQiOT2PJ03wLkVg0sTjG8QFIwPWP/5WNAtQavE6CbFjih9dEG1rnCWT/6A1KiP0fw6g7+7K5nOZQYA7zUR/KM5cqf4a+O1SMvURXy4KomPBywxRD9h6NbH6MjoDGdYFlibSTJNXUYc+iyO2U40DByNEg== X-OrganizationHeadersPreserved: VI1PR02MB6062.eurprd02.prod.outlook.com X-CodeTwo-MessageID: de868c75-0260-4ea5-882e-992d609cd4e6.20261012080632@westeu11-emailsignatures-cloud.codetwo.com X-CodeTwoProcessed: true X-MS-Exchange-Organization-AuthMechanism: 04 X-MS-Exchange-Organization-Recipient-P2-Type: Bcc X-CrossPremisesHeadersPromoted: MI3PEPF00008492.eurprd03.prod.outlook.com X-CrossPremisesHeadersFiltered: MI3PEPF00008492.eurprd03.prod.outlook.com X-MS-Exchange-Transport-CrossTenantHeadersStripped: MI3PEPF00008492.eurprd03.prod.outlook.com X-OriginatorOrg: m1wmgpm3xrpm87txzdfw82by7.smtp.codetwo.online X-MS-Office365-Filtering-Correlation-Id-Prvs: fe1d0692-b49d-4762-4eec-08df2837ae67 X-MS-Exchange-CrossTenant-OriginalAttributedTenantConnectingIp: TenantId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;Ip=[20.93.157.195];Helo=[westeu11-emailsignatures-cloud.codetwo.com] acceptlanguage: et-EE, en-US msip_labels: MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Enabled=True;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SiteId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SetDate=2026-10-12T08:06:11.499Z;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Name=All Employees (unrestricted);MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_ContentBits=1;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Method=Standard; authentication-results-original: mx.microsoft.com 1; dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=ravimiamet.ee; This is a multipart message in MIME format. ------=_NextPart_000_0235_01DD5CA3.8EC8C590 Content-Type: multipart/alternative; boundary="----=_NextPart_001_0236_01DD5CA3.8EC9AFF0" ------=_NextPart_001_0236_01DD5CA3.8EC9AFF0 Content-Type: text/plain; charset="utf-8" Content-Transfer-Encoding: 8bit Tere Saadan soovitud andmed. Lisasin täiendusena ka eristuse sihtgruppide lõikes: * Üldapteegid ehk ravimite ambulatoorne kasutamine- elanikkond ostab ravimid üldapteegist * Haiglaapteegid ehk ravimite kasutamine haiglas - haiglaapteegid varustavad ravimitega ainult haigla osakondi * Muud asutused - asutused, kel on ravimite hulgiostu õigus, kuid mis pole apteegid (https://www.riigiteataja.ee/et/akt/105022016002) Metoodika on kirjeldatud meie statistika aastaraamatus alates lk 5: https://ravimiamet.ee/sites/default/files/documents/2025-10/Ravimiamet_aastaraamat_2025.pdf Loodan, et andmed on abiks. Kui tekib küsimusi, vastan meelsasti. Parimate soovidega Janne Sepp spetsialist Statistikabüroo Ravimiamet 737 4140 www.ravimiamet.ee Selles e-kirjas sisalduv teave (kaasa arvatud manused) on mõeldud ametialaseks kasutamiseks ning seda võivad kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt väljendatud loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. Juhul, kui Te olete saanud käesoleva e-kirja eksituse tõttu, teavitage sellest koheselt saatjat ning kustutage e-kiri. This e-mail and any attachments transmitted may contain confidential and privileged information. If you are not the intended recipient, please notify the sender immediately by returning the e-mail and permanently deleting what you have received. Any dissemination or use of this information by a third person without permission is prohibited and may be illegal. _____ Saatja: Liisbet Aland (EE) Saadetud: esmaspäev, 05. oktoober 2026 13:42 Adressaat: Janne Sepp - RA Teema: Ravimituru andmed Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Tere Nagu eelnevalt telefonis rääkisime, soovin paluda täiendavaid andmeid humaanravimite käibe kohta. Meil on analüüsi jaoks vaja arvutada ravimite keskmine hind ühe defineeritud päevadoosi (DDD) kohta ATC-rühmade lõikes. Selleks oleks suureks abiks humaanravimite käibe statistika ATC-rühmade lõikes 2024. ja 2025. aasta kohta. Võimaluse korral sooviksime andmetes eristada ka retsepti- ja käsimüügiravimeid. Kui võimalik, palun edastada andmed sellise ATC detailsusega, mille kohta on olemas ka vastavad DDD andmed, et käibe ja ravimikasutuse andmeid oleks võimalik omavahel siduda. Samuti, kui Teie hinnangul on Ravimiametil veel muid asjakohaseid andmeid, mis võiksid selle analüüsi jaoks olulised olla, kuid mida ma ei ole päringus eraldi välja toonud, oleksin väga tänulik ka nende edastamise või neile viitamise eest. Andmed sobivad näiteks Exceli või CSV-vormingus. Ette tänades Liisbet Aland PwC | Konsultant | Ärikonsultatsioonid Email: liisbet.aland@pwc.com Mob: +372 55600416 | Tel: +372 614 1800 AS PricewaterhouseCoopers Advisors Tatari 1, 10116 Tallinn, Estonia pwc.com/ee | @PwC_EE | ee_info@pwc.com "Privacy Statement (hyperlink: https://www.pwc.com/ee/en/home/privacy-statements.html) The information transmitted is intended only for the person or entity to which it is addressed and may contain confidential and/or privileged material. Any review, retransmission, dissemination or other use of, or taking of any action in reliance upon, this information by persons or entities other than the intended recipient is prohibited. If you received this in error, please contact the sender and delete the material from any computer. Please familiarize yourself with our privacy policy." ------=_NextPart_001_0236_01DD5CA3.8EC9AFF0 Content-Type: text/html; charset="utf-8" Content-Transfer-Encoding: quoted-printable
Tere


Saadan soovitud andmed. Lisasin t=C3=A4iendusena ka eristuse = sihtgruppide l=C3=B5ikes:
  • =C3=9Cldapteegid ehk = ravimite ambulatoorne kasutamine- elanikkond ostab ravimid = =C3=BCldapteegist
  • Haiglaapteegid ehk = ravimite kasutamine haiglas - haiglaapteegid varustavad ravimitega = ainult haigla osakondi
  • Muud asutused - = asutused, kel on ravimite hulgiostu =C3=B5igus, kuid mis pole apteegid = (https://www.riig= iteataja.ee/et/akt/105022016002)

Metoodika on kirjeldatud meie statistika aastaraamatus alates lk = 5:
https://ravimiamet.ee/sites/default/files/doc= uments/2025-10/Ravimiamet_aastaraamat_2025.pdf

Loodan, et andmed on abiks. Kui tekib k=C3=BCsimusi, vastan = meelsasti.


Parimate soovidega

Janne Sepp

spetsialist

Statistikab=C3=BCroo


Ravimiamet

737 4140

www.ravimiamet.ee


Selles e-kirjas sisalduv teave (kaasa arvatud manused) on = m=C3=B5eldud ametialaseks kasutamiseks ning seda v=C3=B5ivad kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma = saatja selgelt v=C3=A4ljendatud loata edasi saata ega mis tahes viisil = kolmandatele isikutele avaldada. Juhul, kui Te olete saanud = k=C3=A4esoleva e-kirja eksituse t=C3=B5ttu, teavitage sellest koheselt = saatjat ning kustutage e-kiri. 
This e-mail and any attachments transmitted may = contain confidential and privileged information. If you are not the = intended recipient, please notify the sender immediately by = returning the e-mail and permanently deleting what you have = received. Any dissemination or use of this information by a third person without permission is = prohibited and may be illegal. 


Saatja: Liisbet Aland (EE) <liisbet.aland@pwc.com>
Saadetud: esmasp=C3=A4ev, 05. oktoober 2026 13:42
Adressaat: Janne Sepp - RA <janne.sepp@ravimiamet.ee>
Teema: Ravimituru andmed

T=C3=A4helepanu! Tegemist on v=C3=A4lisv=C3=B5rgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte avada.
Tere

Nagu eelnevalt telefonis r=C3=A4=C3=A4kisime, soovin paluda = t=C3=A4iendavaid andmeid humaanravimite k=C3=A4ibe kohta.

Meil on anal=C3=BC=C3=BCsi jaoks vaja arvutada ravimite keskmine hind = =C3=BChe defineeritud p=C3=A4evadoosi (DDD) kohta ATC-r=C3=BChmade = l=C3=B5ikes. Selleks oleks suureks abiks humaanravimite k=C3=A4ibe = statistika ATC-r=C3=BChmade l=C3=B5ikes 2024. ja 2025. aasta kohta. = V=C3=B5imaluse korral sooviksime andmetes eristada ka retsepti- ja k=C3=A4sim=C3=BC=C3=BCgiravimeid.

Kui v=C3=B5imalik, palun edastada andmed sellise ATC detailsusega, mille = kohta on olemas ka vastavad DDD andmed, et k=C3=A4ibe ja ravimikasutuse = andmeid oleks v=C3=B5imalik omavahel siduda.

Samuti, kui Teie hinnangul on Ravimiametil veel muid asjakohaseid = andmeid, mis v=C3=B5iksid selle anal=C3=BC=C3=BCsi jaoks olulised olla, = kuid mida ma ei ole p=C3=A4ringus eraldi v=C3=A4lja toonud, oleksin = v=C3=A4ga t=C3=A4nulik ka nende edastamise v=C3=B5i neile viitamise = eest. Andmed sobivad n=C3=A4iteks Exceli v=C3=B5i CSV-vormingus. 


Ette t=C3=A4nades

Liisbet Aland 
PwC | Konsultant | =C3=84rikonsultatsioonid   
Mob: +372 55600416 | Tel: +372 614 1800 
AS PricewaterhouseCoopers Advisors 
Tatari 1, 10116 Tallinn, Estonia 

"Privacy Statement (hyperlink: = https://www.pwc.com/ee/en/home/privacy-statements.html) The information = transmitted is intended only for the person or entity to which it is = addressed and may contain confidential and/or privileged material. Any review, retransmission, dissemination or other use of, or = taking of any action in reliance upon, this information by persons or = entities other than the intended recipient is prohibited. If you = received this in error, please contact the sender and delete the material from any computer. Please familiarize yourself = with our privacy policy."
------=_NextPart_001_0236_01DD5CA3.8EC9AFF0-- ------=_NextPart_000_0235_01DD5CA3.8EC8C590 Content-Type: application/vnd.openxmlformats-officedocument.spreadsheetml.sheet; name="=?utf-8?Q?Ravimiameti_ravimistatistika_ATC?= =?utf-8?Q?_r=C3=BChmade_l=C3=B5ikes_2024=2C_2025.xlsx?=" Content-Transfer-Encoding: base64 Content-ID: <> Content-Disposition: attachment; filename="=?utf-8?Q?Ravimiameti_ravimistatistika_ATC?= =?utf-8?Q?_r=C3=BChmade_l=C3=B5ikes_2024=2C_2025.xlsx?=" UEsDBBQABgAIAAAAIQCnDOt5aAEAAA0FAAATAAgCW0NvbnRlbnRfVHlwZXNdLnhtbCCiBAIooAAC AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACs lMtuwjAQRfeV+g+Rt1Vi6KKqKgKLPpYtUukHuPaEWPglz0Dh7+sYqKoqBSHYxEo8c8/NxDejydqa YgURtXc1G1YDVoCTXmk3r9nH7KW8ZwWScEoY76BmG0A2GV9fjWabAFikboc1a4nCA+coW7ACKx/A pZ3GRyso3cY5D0IuxBz47WBwx6V3BI5K6jTYePQEjVgaKp7X6fHWSQSDrHjcFnasmokQjJaCklO+ cuoPpdwRqtSZa7DVAW+SDcZ7Cd3O/4Bd31saTdQKiqmI9CpsssHXhn/5uPj0flEdFulx6ZtGS1Be Lm2aQIUhglDYApA1VV4rK7Tb+z7Az8XI8zK8sJHu/bLwER+UvjfwfD3fQpY5AkTaGMBLjz2LHiO3 IoJ6p5iScXEDv7UP+UjnZhp9wJSgCKdPYR+RrrsMSQgiafgJSd9h+yGm9J09dujyrUCdypZLJG/P xm9leuA8/8zG3wAAAP//AwBQSwMEFAAGAAgAAAAhABNevmUCAQAA3wIAAAsACAJfcmVscy8ucmVs cyCiBAIooAACAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAACskk1LAzEQhu+C/yHMvTvbKiLSbC9F6E1k/QExmf1gN5mQpLr990ZBdKG2Hnqcr3ee eZn1ZrKjeKMQe3YSlkUJgpxm07tWwkv9uLgHEZNyRo3sSMKBImyq66v1M40q5aHY9T6KrOKihC4l /4AYdUdWxYI9uVxpOFiVchha9EoPqiVcleUdht8aUM00xc5ICDtzA6I++Lz5vDY3Ta9py3pvyaUj K5CmRM6QWfiQ2ULq8zWiVqGlJMGwfsrpiMr7ImMDHida/Z/o72vRUlJGJYWaA53m+ew4BbS8pEVz E3/cmUZ85zC8Mg+nWG4vyaL3MbE9Y85XzzcSzt6y+gAAAP//AwBQSwMEFAAGAAgAAAAhAKtHP+/0 AwAAuAkAAA8AAAB4bC93b3JrYm9vay54bWysVttu2zgQfV9g/0HQOyOSoi4W4hSyLtgASRGk3mT7 FDASbWuj21KU7SDob/UH+mMdSraTNMXCmy5gSyY5Ojwzcw7l0w/bqjTWQnZFU09NcoJNQ9RZkxf1 cmr+OU+Rbxqd4nXOy6YWU/NRdOaHs99/O9008uG+aR4MAKi7qblSqg0sq8tWouLdSdOKGlYWjay4 gqFcWl0rBc+7lRCqKi2KsWtVvKjNESGQx2A0i0WRibjJ+krUagSRouQK6Herou32aFV2DFzF5UPf oqypWoC4L8pCPQ6gplFlwfmybiS/LyHtLXGMrYSPC1+C4UL3O8HSm62qIpNN1yzUCUBbI+k3+RNs EfKqBNu3NTgOiVlSrAvdwwMr6b6TlXvAcp/BCP5lNALSGrQSQPHeieYcuFHz7HRRlOJmlK7B2/Yj r3SnStMoeaeSvFAin5oeDJuNeDUh+3bWFyWs2timrmmdHeR8JY1cLHhfqjkIeQ8/NSmmNsY6EoQR lkrImisRNbUCHe7y+lXNDdjRqgGFG9fin76QAowF+oJc4cqzgN93V1ytjF6WYwU7sJwQy2a9xARV jyfdikvRNkU9Kq+F6jQ1L62/eV2Lu0607Z3k66IqoFbqTghrb6XOmn/7+u1ryfvceqFs/tZG/0Hb PNMFs6BiY1bj7x+rB8nJYK/fKyUN+H0eX0APP/E1dNQGHeY7x59Dz/y7p0nkpiF1PeQS10fM8WI0 80If0SiaERqloe/4XyAN6QZZw3u12slEg05NBpp4s3TJt/sVgoO+yJ8JPMWh57oYh8jzbQ8x27aR jzFFdAKbhjGJWMy+6FT1gXhTiE33LCg9NLa3RZ03m6mJCAUbPL4ebobF2yJXq6npEJ9ByDj3hyiW K2BMyfAcGEczm5pPFHalbhghikmImBszFNpQgCRKSEJxRKMQCqCL/4LScPQCteFu1INdQtlracAh r89lXV5iGjLQm8jznAwQ++cyXmbgD30bAicE04mOEFt10anhDtIsgB9hOPTwhCGc2A5i/oQin9kU QaVo4nhJnMwc3SD97gj+jxN0cEiwfylpluAENZc8e4BX2bVYzHgHWhoTAr4vyc4cf4ZtoMhSkiJG JhjNZi5DTpzajkfiKHHSZ7I6/cU7zy/fGp4WXPXgbW3rYRzoa7qbPUwuxoldo17ZLriOdd13T/9b 4CfIvhRHBqc3RwZGHy/nl0fGXiTzu9v02ODwchaHx8eH19fh53ny134L66cFtX5oeEzYBNtJiGw7 Yoh5qYf8FDvIZh6LHDZLCPaeG15usvX7+k2ZtVdk9PIvxu400v3X4MHu/5fRCbVbAssP1huIa/qD vw5oZ98BAAD//wMAUEsDBBQABgAIAAAAIQCBPpSX8wAAALoCAAAaAAgBeGwvX3JlbHMvd29ya2Jv b2sueG1sLnJlbHMgogQBKKAAAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAACsUk1LxDAQvQv+ hzB3m3YVEdl0LyLsVesPCMm0KdsmITN+9N8bKrpdWNZLLwNvhnnvzcd29zUO4gMT9cErqIoSBHoT bO87BW/N880DCGLtrR6CRwUTEuzq66vtCw6acxO5PpLILJ4UOOb4KCUZh6OmIkT0udKGNGrOMHUy anPQHcpNWd7LtOSA+oRT7K2CtLe3IJopZuX/uUPb9gafgnkf0fMZCUk8DXkA0ejUISv4wUX2CPK8 /GZNec5rwaP6DOUcq0seqjU9fIZ0IIfIRx9/KZJz5aKZu1Xv4XRC+8opv9vyLMv072bkycfV3wAA AP//AwBQSwMEFAAGAAgAAAAhAJdHzenPHAAAOXAAABgAAAB4bC93b3Jrc2hlZXRzL3NoZWV0MS54 bWykXWtz3MaO/b5V+x9U+m6K3Xy7Yt+KPKP3+7WfFXkcq2JZXklxkrq1/31PswEOcZrjq0nm3iT2 8AhsdjcawAFA/fSvPx++bHxfPD3fP359t+myfHNj8fXu8eP911/fbV5f7bxpNzeeX26/frz98vh1 8W7zr8Xz5r/e//d//fTH49Nvz58Xi5cNSPj6/G7z88vLt7dbW893nxcPt8/Z47fFV1z59Pj0cPuC vz79uvX87Wlx+7H/oYcvWz7P662H2/uvm1HC26fXyHj89On+bjF7vPv9YfH1JQp5Wny5fcH4nz/f f3tWaQ93rxH3cPv02+/f3tw9PnyDiF/uv9y//NUL3dx4uHu7/+vXx6fbX77guf905e3dxp9P+L/H P4Xepv8+udPD/d3T4/Pjp5cMkrfimNPH77a6rdu7QVL6/K8S48qtp8X3+7CAS1H+7w3JVYMsvxRW /E1h9SAsTNfT29/vP77b/Pd8u+pm9YfZm6acfXhTzorZm/bn8sObYl67qmq7et7u/N/m+58+3mOF w1NtPC0+vdv82b29Kd3m1vuf+g10c7/443n0542X218uF18Wdy8L3MRtboT9+cvj428BuI+vcoh8 7gFB5O3dy/33xYfFly/vNmcez/r8v/1dwp9xi63hHuM/6/12+j199rTxcfHp9vcvLxePf+wt7n/9 /IIbh2kLW+Xtx79mi+c77FHcOuuF3j1+gQT8e+PhPugattjtn3Gs9x9fPr/bbLPG5V3RVEHl/gq7 DtLufn9+eXz4n4jon3+QgKu9BPz3j3i9bjLfVq6qvZHxy+L5Zec+DO+H8rBKvbxykNfPzDCUV4rB rXsx9SDGTT7ZK8U1Ig4HkTyly7O2qsq6tTP1SnmdzjuOOhVYT838K+W5YSGX6+DbrGrywv2tZXC6 Dm65EIX7J4/sdEncck0g0ZX539soTtfELRelKLPSV037N59ZV8UvV+WfPbPXZQl7WNa5qP7+M/th VeqiXS5Ml0oM50fU9f4Umd2+3L7/6enxjw0c8BjU87fbYC7d2zCwybMCh0TA/hzAOAMwx1DdZ5xf 39+XzU9b34N8wWwLputPLdxkuFM40159pwDuBzfcqMqHG22NxWIWXi82gEmsmxaLCX292AAOYsNE j8cWzrxXP3IATwmBhhghAAEaT+F48PdP9MOFCzKiLRjmczmd/dpuT0DKzq7tB8FgFgcxy+nrxcwE ghkZIN5KmQsEDzFACgvZmYCUFrI7MZbKQvYmxlJbyP7EjSoa78EUhgZ8GDEe/xmeiRTjSMSMIa0d zfEEhJbgZALiaClPBTNWU0frdCYYnHLLpaQHP5/C0INfyIPjkFzKoaW6FMx4Tzhaq6spDC3W9RSG ZvlmCrOcZqOdsBmv184AfrdpHoGWZjuFeFqZDxHS9Ceng2/kipwmfRYhbYQ0dVZWhcv1Q6s4j+Ci B7ely1vfBM+macMP0PTtGHDri6po66yuWt/hQ/O4G8FwJcIhX+eAtUWedU3AJug9QQeX9vv7xvu8 aX0Nj6NxAc1KF9FdD/ZN2fmWdsyBQbRdW9Qk4zAifJxKeOlt7XwJ0xfHR0tzJOOL6Lp2XVWUPmva CCfZxwbt8fCNowGeWEhTdVgkq8ynMsI4g2VT5W3eZHklA6R7ngna95NSdW2VVw6Lg6kMH7r9uUG7 0vmajpILQcSt4Yqm7VgrBVHFZXBt12UN7YIri2nKwmOK7XNeG0y6oW/sdVcvN7zRxhDWv9pWBrDV Rk+qsT0BIVX7ECFxUzR5ljdYpFWqNovgqJdNlbWFz2UpU32YR3Cc/KLydV22YDLqulcfWqodA246 10EjofZR1VgvI1j0smw99j12cqkbnyygoKNellBH/IN9D53rP2QMIzrqpXMeZxOd0gcWUVZtReM7 jAjRy6JyQcXCRo4zS4t0JOOLS1CEXVp5zG0Vx0eyjw26qeuCT60Ti8AadWSvTmV8USud74Lu+Iy1 UVBRG13R5hWeA+GEnbBzAyvKzuU0YReC0J1QNQXd6lIQUQ0dNL9tM0egKwtyHZ48o1tdG0xTeXry G3O9xs6ZdnzhEbxeDwOY9JBuuz0BoRPkQ4TIUZ7jiEHUtlIPIzjqIYiFLHf10j7SnMwjOM6+r3xg MxAJd40vIZ82444FNxX2Y1dkXVn2mkjuZwSLHhada4omHO953Oc0CXuCFj10ReGCNa2nrdV+REc9 rNu6zFsa6sEY0eS5bwp68sOIUD1sMEcFNMu5OD7ayEcyPtHDrm6qyrmsKCfPiWODrpu8hdra6Tmx kLbESpFNPpURiiZWvizKGmSRFXQmKNHEGuawhZlv6H7nFlYVOU/IhSDEIFYVXBN7q0tBRE0sOojI apr4K4up4URlOET0QwfWtUF7V5G0G3PdjQ9TYxodvOs1gvSAJqWk6druJRKGzpwPgol7wmd50cFF GD60TjNBR730ma/ybmlLWdXmgpbFyH1dhQOtqmkCdywOTA4g2JYV3X1XcKKOMEt5CRvqah0umUWF R32s29J71+B4l+1O0vcFHhUSmlHXbBcJ4auCNtehINRhrVvsrw6PPO0OHukIxWMFL1Z7n7W5jJAt o4VXMHsNe6wEKeCpsUbqGEUla1fUUIGlm0OqqfCom2UBBhSWnm2kRXnvW3ZVFSHHtPPsdlwqQnxV erQre7miw/faXmazSD88bRQDpbqGBkYOzHAgCU02gaGJ+dDf9d2mGMYG9gJGZvjQg8wEHTWwBsXf VjF46H+C0HNBy5xDVztoS9bBiZnwDHcMushdCUK/zHzd9HegY21X0KKNcLDypoNwbPgp4XsKj9oI 4wgXyDcZn/H7gotq2MGl7pipMQh4BS2mwG7aQ4GIHiJm9I1vkKSQwJYDRx2bhOyFLxxuDEWMH3ry YwvvcBBxWHhCEuGGtE2iiEKiiiK2ObyArGEnVR9FbGNVd22TdUMIQ2M7t3BwxgS4UEDcEzWWjAyk AqIaMoNjr7qOxF/TdSv7xl5darg1hGtxyCH1xYaQOZsJTMGkjWDEOQqpHrZTM4FE3YNnV5RNsTKU nAt6cEUQxFUV+/M7hILP4zr4jB3HGLsCFHVDAqVrCrBA3bR3uadwMX5QTnjbWakxIZM1Ao9ah1Sg Z8b/wCIwQNbLQ0GI0pXwmgLbUKywZkc6wjjj8B3BnlRZKb51TkfZsYVDRTH35I4SBCEDk1KnOsao cz7HyQZ/lN1RRUWdAwWQO7iAZaJrceshoRIIMfjSqbIJIm4ChCY53epSbyX+aNMhTKXte2UxMK1d xkzZNcnhAPTGXncj82x1b61ES0gZku4VzNBMYZiiEYwcvx1MjifrPxOIMKaAYBaWusfJB0HHaccR 18d4WMNoWOlM2yF0WSEWyxCBTLJyu4IWRQThB+PiAsUKZjaNN/cULlFhB64Es5/BHaVH3BekMDMd oqDARuhDcnBo0W1d5y2zpwJRK1jl8LngvPnpgO9IRyrLAMtbQskRR6+wgpJmEzgqCHxqBi0GdFPD LOepjjKqZAGiy/m8yLyv+8OVUxoKj0oH9qrAgekybIYYuBB5Y+E1QuMOwZwFXSgo7hdQ1YFgZwpH QVFTyxAogWVzcGJ6f4fJHIKDWwKhk7XYhP100o69tnBktLFKWeLFxulEej8cOB5Pg4laZUXXym2G nD9rMnM8UxgmeQSjuY+scs0ycO7oYJsJWtMgsGYcFMwFIskPlDYURQ3d5PBix+KwNK7EbLeyKehR dgUtOgxntG7aBol/Nvl7ChSvFTpRgYqC6Y/LSBtpX+BiRsuqKhLnNU60IJDRaJnTERmitXWD1FCb w6+W445m/EhHKAR3jV2Rw3etRck562Hh3mFGySSdEMQXiTNwqmOUxBGiVhA7YOnEHUp0Nj60GMoG eYzOgXnCf/oPDeBcpSsxCx4v0ViRqJmPCp4u+7EC0XASbrPw01MKeKU3rUJ+v89yXy+/CuqWKOMg nwsCQt3LGnFkLAkYx5FMa233Ei2Twxb+g2CESwgpHE70zAQiwSNYzw5H9vChOZ4LWlhtHN1VCzKj w0JPBo/xMRQNiK9QjlSXfXKQNH9XZIsC4rxHVgY7omPOZU+BUQE9rCf4mwrM03RyQ+BiQ2G+mpL2 xYGFYB8iYuXwMT7LYDgDqdzAJLGuHuno5LxroCoOygcvvp/VJHCU6g81mWBn6sSJJUzhW0ePcCq3 Ra2ROJ4ewQCyjkzdyGMIdYNkY0g3Dm4TpxtVaoSHkqqEwxGBcZGbuqvolpcqQxIdrgncEmnOFYGQ v4FJpntdE6jiibohANJvK1idUCzw+uKnWFpgtDFhdSYwCasTMepLgUaBn2LXZxbK4mB0xfwh+AkJ RIuZC0ZmHCpVNoGzl5QxoXcsummRgfBF1pSsVrsCFP0rGoSTYOY5Ot1TmDivKCYA1YEtJJQTGbd9 gUftK0N5AFeAHFgIfAOwt6x9Ut0hobgrYV4qlPnRFB/p4AQXjBCcUBRGTBJQxwRHIqdi9uKEMF3R 4n92eKeCUeVryhL2DIzoNFl0pnDRKo90EJJfyghzgHpu4aiIQMzC3qrMjxy1yDbyrrlUKcLheJjb kZ/YW7cri8HOy8FOjLh/e9drgucVHR83FlB0IyNmQ8xQKvB6fYyFBUYfE3onxZQJvRMxca+gxCU4 cqMPnWOzUGq6VE2kH3XLT53rc0Fr+NBAeoYgcnoj7hg0MihYYsRkTITuCkxUFJ4nAiyosl2WPUVF Da1KJA9gf5LQMj5OVExUDjF/fyBiBIAdRRIOBaDkTt0W8AVyrn7T0QiZjZoasCu8x48tqgEJQ3JO CIEkLR01pzoeIXJcFaqcSMyZgsQAhkKAxNCcWxB6Abj4TQHCosOKsqdpil+4ukZ/POoiJw/tVXrK m1VXrUKFnP/rFSpWCIwViomt7VBfTdEgV0V8EIyudHA3R6cHPeZM0JLQR56x6uql+iVpi3h/mXAU OSA8w5lZcaJ2R8QKsEb2u8RJ55DNn6BidgU9OJ0o50I6K0vqOfYUKE4naBD4nMVwxidRXxyupCwQ uTODdyACBdGFYImNnhRuqCfZVWBDywyGeerEOdIRRrhHNVHd1MEFXGH7TMlM55FEoK12YiV2cLN5 yU8FIpbPd3WNADs5BM4UNrCnoToo43jl3MLKEgE4GzpTVwNahvM8lyoj6laNQzpjAvLKYuBvgAEb nfyJQtoKGj5Kb6y4ZqQ7VilD1v/1ShlrBIxSJvTLBCahXyJGPKIq5IlG6fxEKSNa8hnw/kBSLR0A Qs9dREvEDUoCLBlcVpS7hdmk7bRj0djG8EGR15hG7wpaNLMp8MmRgtHsCincnsKlEhUUCfIhOP5X ZfbjyMW4hbKqhEw1CJSccUXZodxSWRkcXiFeXTXCIx2hROPIUMJiLkttksx+vD+O+760tgFLmcSF FhJqBYjbOdUxRpuIYLRyKBpMokJTRQMmBhMyYRUNyoN2S4JBQcjhi5RpYhdtZQzKnDlevNIhS7yY g8/kkOHaYsqEh7H1NSMnwChk6PBZozMlLa/hidzuJVpSpuTyGsGo24kAhZVQEFEJc9guDjjmghDF y1GaAtK35jKjHQNDOSa8SiT9NOPNBIygReNAQ6IcEyY2l3wDjXJP4VHjulC82lYZcnCTDN6+wKPG IYOPc5nZiQODgSnukPxuxdwlZXuHglb9Kwsc9hmXAx/pMEWPPLKUYNHpbDq2KIc8IRe2EQLpIzox TnU8UdcQPHU44WB8JKqgg/lM4dEmdkF5wUciJxvnj8tpLLxuUWIAN2X40C67UHjcIoioc6ga1H86 JL1UuCgdonqoXadj4Xj8iuAtykHAhelhy/BrC0duBpzhKNainXVD8OAqjJIAVoXXqc/ZD514cGLj HqSj6WDFRXu7deoQ9vue1ZW3i3lgHou93Vqp19AXiKezXXp0RG8rqG/T66P+fflqxaxEoT8e5lp5 JR9JcizFVIufDGmcEkkWavqinbm1+Pa+OXZle6AMKRKdK2Zp+qId0lqkY+go065AGUD8ZsUApi/a AazFsuBYDQOoh9zHvnyzYgBjOmFFx2bYmf+4o7EX8h9aGqcwSU+jgn7U1KiYsRfOhQWK+VFb4xSG 7MHu1HjICO1NjYfrdqbulbQ2ToLIjToU0A+bG1UQ9t+gznTmHE9hyPk4mcIknVUKwj5aNh1yZlFB 8AFXdzhOgjjY1Of/YY+jgsZbJGlynATRwl1PghLbKLGoud1ywq3CrxVw+jSY5PTE9gQmaXUUTPS3 4ACh3XFEIXPCQ9DR1w11V93SP03aDeeC1vjCF2Vfq9W4vi6TA05Co54MRRTIxIUEA/xVSy3sCloL ABxqV9AwGNKVk8WrCpcyAFSTuhYNRSGjNkE07Qs8Hp4eFS0Vx2oHBKkKxIdECQlEs5BIvNQFcjRo 25ikhHSMwiCh/A59WcjAav2FlX5s4SEwQbGtxZwQBoUFKFCndIiOUohYlC01yDXQs5wpSqp20JgR yjjUW+b0/rmFl6GGkLghRQjnDk6bBn+piOjloqASFXwjhpJOkisL71+IkjDX1wRKuOIbAiBbN4zb aGuxVjTao/9DJ+QUhuvsBCPaiihS62OmyjBmghZtLdH2xDmKuUBERbHdHEIau1I7FgPqDalGOg13 BaPqiAgDB0PGFXJ7ChM1RHtbz6pw0dC+4ET/2qrztH0OCIEUHic8BKHahxs1iKq4PPtIhyRaV5fQ 0b6KldTN4jyKvVmTTggS4jFyCU51UFIrh85QZD1ows8UJLoGpgiMJ0eYFgRulWzPhQI0qeVIwqUC pL4GrLd95CsGhAzNyDhwwt/CcdhbcTd0fdSTajVrrSaOYqJBg4nXKQwTr4IZeB7Ubo7Ti3TYzASu pA9qA8bopJFK4MIAhfZGmpwdQqDQiT1OQWjyw1Wo8kYn3ope+j2FSwoE7xwAS5Bx1mBfYKJp2Pxc InNgESibK2inHQpCNA0VSUgFoMZAq1Q57a8jk9RHjp0C8jdJMhIMJQ6czzghCGogeGynOjbt729R 6UuKcKYYyTI2BWps2QCeWxDawjirr4C4yKGAkbKMClCqFEUHnDe9IgwchmQk14xhPpWuj45Oq2dr dWkUE10a3K44hWE+VTDNEKjO5Jt2+GYu3xTDNzvJN7vyzZBcR5s5MowNLe2ewiS7jldvwKnKaAPv C0ryCyVcT645s4jQdMz5P0Fofh38P4h5rsc50vGIBW/gP6NUnY3SsYU18IQ5n3FCEJS5cMfHqQ5J PDt0J8Ghxrjkw8l2hWthNqpfkfVbelx2O58zvHMckSlC6lzw6o9EJaS9QtJ/aOBP038qRTAeaRhu LL22GDjanIe3AORaV3h1672mKu2eYCu8XUxguNRMMLInQpJp2VefJOZmghavDqyyqWwhqzEX9ODg Ie2ALiL28OIgh/oIuCVoY6SISyQNLp7DMYle16TgU3Hi46F+E/388FSFQubcu8Cj7uG1IygNtzc+ IATqGjnQEoS6erhfaJMICcvJQEtHqKl61KeFyJfzQ8eEq/HyFRr9CUPwugtSq1MdnGgh3gTC83+m EEm4lzVyHlzcaTFJY9SFXhcfg525S72u1od9vaEzYaiepp9gb278A9awrEUwF5EfNpwd14dNYJL2 P8GoEqFIb/zx8zd0JMzkB6SiBY5UApkLRPQCDbKJ1xYHvyxfIcCuSBicNtifDHZBP7TV9xSudSt4 YQV6IOzM7wsoakyJ7mHWlzHjjsvcVSQ/v3TXwts/R6yPFXekYxJ3DRPbotptmFzOzVk4TCnd/sQC MD7a6ac6Pm2rRVWtHdKZIiQZlwDOLYB+/EKvyrKxmxanD1kG1YQr/YFRa0H61Y35ymrEWvmNYqKf gM6d7SlMQhZEORrSoPKeiyRFyjJ1PW5FT1K4c4HHacMbWgKBxpZk3ETQoaAMETdhdkWMZq5zpIJR 9TOkGBMXTurpo04gy402BnTAs1KMczoo0OWi2wO5q1RwVWhdsRIOBSBq0eZ9gjwUjsUPHetH+hRx elEfgsZuqLYVemxRyKUm7QKEgHua6IMU7Ys+FIgJmJ3TsYsBgaHKuKDn3GLgNtihXuh1MSC8bJd6 XQwILdPV8vLSgMjA5SfYgAxXuf2mWCv31qOptSaJTCYK/pPIZFzwj9cPodZ0VExFh/BM7iovUgnT TfM5F4TaY1+gQB9RMQh21pl4YwWGd/AUcL8ST2JXJA6cN2qmUFqJtxNy4kmB4oKhXBj1Hjl6+abZ boErBxDsE22wAwtBC13OvSWHAhnYbsRIeTlRnHmkoxP3C7w9SrHQEcQs4LEFwkeDe8gMd4LBSwYT 0k3q7aXUA8XdqGbhRJQOX3rWcrx5CD4hLfu5RaG8LQ16bHF/mXREXaoM4d3QQpgo65XFhEZ8vBTK 7ptrxtCGvrHXyxGva43TWonmYqKcnzb09hQmiXnG5fx4Zw7eJfaDPlORKNqGqtqyHTORdmLmgla2 rYCeoNQvR1Uia14chADxRoLwhkq8SqeOwi16V8SK+iEfgTccobtaX5eSKGEUjhfXhJJAtBo3KO4P b0WKrlPCQYxT8iDiEecmgZCBoAgZb2RiIyaV7GKV8L5N0Nnwj8RdI/iRPlKEo0QaTfAoglKjR/Bj C0drEmgwmtMTxoDf4FLIU8FIHTJsIppdkyqvM0WJRmJG0NTN78s7tyich/ziiQtFxGXGVkjqHBUh FANSUegvsTN7ZTHorUOjEtnAa4vBaZvQEKbRwHUj4sfq5FodAUVa7c8dkdsTmKTFRjBjbi5KHnNz WtmvVn5HfmrJ1u3KN9qbhpjHo+ONa4AVFfUjkAlIz/CM7QtKbFOHRm+7LgcGEN5gQAt3KAANd1Bb BwaJ331ypKOJmoCeTbQsJJvt2KIA4m1yQnJwr4QPkJoAsUagv9Nsq45Ztr5DHw5q8OyTn1sQ+obY oTPV92iTJQGXKkD8MxwnCQt/RRjQlRm3Fl0ThqmLG7q+qs+zWKsAokdT8W4SJaVFEkkbjMiJ6x7e 76Mvh+yPzIQ0GFfcI/2Cnks6AOciUIJLvJsyr+H3wYQnsdK4Ht+j1RK9lKjhxwtGpgoeROxAvyHg COX7hRQ8JEyCVJuLC4i8Lt6GgoLV6TeH7Yv0qGYozQW5l1ifcYk9sjGgoGh2DkXKwMOh7Db4Wit6 vY/0kcQRbBEdIW5D4auEXBxLmQJ6mCrMfeIOEgZdDkxQnuooJZ7C60qw7CtfyHWmcNFFvMwB+WGu Aj+3qDA9NH8XiogbAxaZnexLRUR9LHz/bkQ2Q6ZYHm+sCanhZXUuzce1FYmXhXEQZsR1ozPE2KNy rWqHHk2qyTnZKQznZAUzskfyzcgeyTejXFHyza58o7kicF1gEJBzFKeICQeFCwkX3kQCp5B5a0FJ zggvG2MazgBwL477DgWgGSO8cwAtasPrs9iNOdJhCQ8HLhr9GGzHji0KdDR3Q55YBNj5pEFaByYK goRvMAzLzL/dQ2cKlwbpDlkj7p87t5jwwh8yVgpQX5wT1ZcKEOUIL6sm1bAITgFd28usCPbqcktY NVirNAG/dSppwmRiYgrDxIRgxmoQJY/VIH4zVgP+ZlfkKBeNRGCoLqO77SlK3DI0DsF5q/UdcOzv 7As8qgF2OXspBxaASjrm3QQw+GcoZIMV5KIBHZb6Z6HACMknZedI6LGFh3FxnEIIvFuWZuJUB6a8 WxITnClCIxRkcjltYyF01FzoVdn19NCXenlERS+/6t8cQvvpOv2J8MvP+kYD8fKWPxG3dvyVZfGX DX27/XVxfPv06/3X540vi0/9ryBDxPIUf0dZnuHPL4/fwi8mC79B65fHF/yGMf3bZ/yKvgV++xCo 3M2NT4+PL/qXwO4Nv/Tv/f8DAAD//wMAUEsDBBQABgAIAAAAIQC7WB9rxQcAABYiAAATAAAAeGwv dGhlbWUvdGhlbWUxLnhtbOxaS48buRG+B8h/IPqSkyx16zHSwPJCT8/aM+OBR3awR0qi1Byxmw2S PTNCsEDgPeWywAKbIJcAueUQBFkgC2SRS36MARvJ5kekyG6pmyNq7fED2Q1m5tJNfVX8uqpYVU32 /U+uI4YuiZCUx13Pv1fzEIlnfE7jZdd7NhlX2h6SCsdzzHhMut6aSO+TBz//2X18qEISEQTysTzE XS9UKjmsVuUMhrG8xxMSw28LLiKs4FYsq3OBr0BvxKpBrdaqRpjGHopxBGqfLBZ0Rn5B0Sq9SON5 Kr0HmxlGDKaJldQDMybOtX5iiRnsfOVrhFzLARPoErOuB5PN+dWEXCsPMSwV/ND1aubPqz64X8WH uRBTe2RLcmPzl8vlAvNVYOYUy+l20tooaDf8rX4DYGoXN2rr/60+A8CzGTxpxqWs02+2au0gx5ZA 2aVDd+fAr9v4kv76Dme/0+oHDUu/AWX6G7vPOO6Mhk0Lb0AZvrmD79WCfqdu4Q0ow7d28I1R7yAY WXgDChmNV7vo1kG73crRW8iCsyMnvNNq1Q6GObxAQTRso0tPseCx2hdrEb7gYgwADWRY0RipdUIW eAah3EsUl2hIZcLw2kMJjrmE4Vrg+xB6jVqw/TcWx4cEl6Q1L2Aid4Y0HyRngiaq6z0CrV4J8uq7 716++Pbli7+//OKLly/+io7pMlSZKkvuCMfLstz3f/rqP3/4Nfr33/74/de/deNlGf/6L795/Y9/ /pB6WGqFKV797pvX337z6vdf/uvPXzu09wSeluETGhGJTskVesojeEBjCps/mYrbSUxCTC0JHIJu h+qRCi3g6RozF65PbBM+F5BlXMCH6YXF9TwUqaKOmR+HkQU84Zz1uXAa4LGeq2ThSRov3ZOLtIx7 ivGla+4Bji0Hj9IE0it1qRyExKJ5xnCs8JLERCH9G18R4ni6zyi17HpCZ4JLvlDoM4r6mDpNMqFT K5AKoSMagV/WLoLgass2J89RnzPXUw/JpY2EZYGZg/yEMMuMD3GqcORSOcERKxv8GKvQRfJ8LWZl 3Egq8PSSMI5GcyKlS+aJgOctOf0xhsTmdPsJW0c2Uii6cuk8xpyXkUO+GoQ4SpycaRyWsZ/KFYQo RmdcueAn3F4h+h78gOO97n5OieXuNyeCZ5DgypSKANG/pMLhy4eE2+txzRaYuLJMT0RWdu0J6oyO frq0QvuYEIav8JwQ9OxTB4M+TyybF6QfhZBVjogrsB5hO1b1fUwkQaav2U2Rx1RaIXtOlnwPn5P1 jcSzxnGExT7Np+B1K3SnAhaj4zmfsNmqDDyl0ANCvDiN8kSCjlJwj/ZpPQuxVbv0vXTH61pY/nub NQbr8uK26xJkyK1lILG/tW0mmFkTFAEzwRQdu9ItiFjuL0R0XTViqVNuYS/awg3QGFn9TkTjNzU/ p1gIfvW/6X0+WtfjVvw+/c6+vHJ0o8vZh/sJ9jZDnMZnBMrJbuK6a23uWhvv/7612beW7xqau4bm rqFxvYJ9lIam6GGgvSm2eszGT7R332dBGTtXa0aOpdn6kfBaMx/DoNmTMhuT233AJIRL/TwwgYVb CmxkkODql1SF5yFOYH/IN7uYS5mrXkqUcAnbRmbYbKqSG7rN5lManfB5tt1p9pdqmQklVsV4rQkb T9k4bFWpDN06yAc1vw11w3Zptlo3BLTsbUiUJrNJ1B0kDjaDbyChd84+DIuOg0Vbq9+4ascUQG3r FXjvRvC23vWajYwR7MhBjz7XfspcvfGuds4H9fQ+Y7JyBMDW4q6nO5rr3sfTT5eF2lt42iJhnJKF lU3C+Mo0eDKEt+E8Osv77j8UcLf1dadwqUVPm2KzGgoaB+2P4WudRG7kBhaXMwWL0RWs8QAWnYdm OOl6C9g3hssogeCR+t0LsyWcwMyUyFb8u6SWREg1xDLMLG6yTuafiCoiEKNR19PPvw0HFpskkpHr wNL9sZIL9IL7sZEDr9teJosFmamy30sj2tLZLaT4LFk4fzXi7w7WkjwFd5+H8ys0Zal4iiHEmge+ 9u6cSjg+8DNXzymch20zWRF/NypTnv2tQ64iH2OWhDgvKeVsnsFNQdnSMXdbG5Tu8mcGg+6acLrU Ffa9y+6ba7W2XFEfO0XRtNKKLpvubPrxqnyJVVFFLVZZ7r6ZczubZAeB6iwT71/7S9SKySxqmvFu HtZJOx+1qX3AjqBUfVp77LYtEk5LvGvpB7mbUasrxKaxNIFvTs/LZ9t8egHJYwiniCnLTrtZDHem tUzOhPHtlM/X+SWTWaLJfK6b0iyVPyULROfXXS9wdY754XHeDbAY0KbnhRW2FXR2e7agLna5aLZg t8JZG3ujX7WFtxKbY9atsNladNFW15sTdd2rm5m1w7KnNmnYWAqudq0Ix/8CQ+ucHeZmuRfyzLXK O224QqmgXe9XtWavMQiag0qt3RxVGvVGrdJu9uqVXrNZ90dNvzbsB58DPRVGfjP7/GEMp0FsnX8E YcZ3PoSINgde92Y8qnLzoUPVeN98COEHjg8h0ER/5OCBI4FWMPIbQS8YVAZDv1VpBMNWpX1Q71UG QWsY9KBot8a9zz10acB+fzgcj5tBpTUAXKPWa1Z6/fqg0mqP+sHYHzWGNQDn5eca3mJ0zs1tAZeG 14P/AgAA//8DAFBLAwQUAAYACAAAACEArPZhn+0EAADDHQAADQAAAHhsL3N0eWxlcy54bWzUWV9v ozgQfz/pvgOizymQAIUoZNW0RVpprzqpXWkf7sUBk1hrcGScLtnVfZf7LPfJbsyfAG25Jilp2jwk 2MDMb2Z+M+PYk09ZTJUHzFPCEk81znVVwUnAQpIsPPXrvT9wVCUVKAkRZQn21A1O1U/T33+bpGJD 8d0SY6GAiCT11KUQq7GmpcESxyg9ZyucwJ2I8RgJGPKFlq44RmEqX4qpNtR1W4sRSdRCwjgOdhES I/59vRoELF4hQeaEErHJZalKHIw/LxLG0ZwC1MwwUaBkhs2HSsYrJfnsEz0xCThLWSTOQa7GoogE +ClcV3M1FNSSQPJhkgxL04ct2zN+oCRT4/iByPCp00myjv1YpErA1omAcG6nlOLO5xAmbVNViqhc sRD8dPbXv/+cnZXfqjadaKWY6SRiSS3NAsOlS8ffE/Yj8eWtQoV8ajpJfyoPiMKMIWUEjDKuCKAC aMhnEhTj4onLlWCpcos4Zz/ksxGKCd0U94b5y0vEUyBWIc+x5VxOq1JATCDIOdJCdRuA+6J+ThDd WbH2gg6+mHuq7+uODh8ptWHo4Yrm0uTSow2D3lRZR/QOMSp3YgqhJpRu6WkDPeXEdAKZLDBPfBgo 5fX9ZgXMSaDoFIHOn3vh6QVHG2No7f5CyigJJYrFVZOvtqoIIhNIP79wXdcxbMdxXHNkmGbOz3n5 OElCnGHIKUgpmTcNM2BUgH0BcgeCi5MjgGw/sQ+g8/SGIA8G8G/OeAjNriqQkoHF1HRCcSQgiJws lvJXsBV8z5kQ0BCmk5CgBUsQlWGu3mi+CU0S+qGniiX0s6r8PeaHVHGwhgrbTppyK/Y2osP8nTQW njq6o3rF8lqXvhpMSSUgZoApvZMU+ha12ncWNVo3LM5kM5JdXF5CSSwvCyYWA8nQprRCdkPsSAeC 7i9XyaKtgq63jU5U27cVtFrRjVw9yHVBOQJL6tElJYskxtUCBlVDuUwVJJBrjADu4mIFkEXdxrwS DniyZWi5cioCMNzV1Nt1PMfcz5fBDZN3dcBjEKZbk+BUGBo8lGvJ53nYR8SXjJOf4CkZ87yk5W32 iCEv+NjJwCYeWczV/TnZFTPgapVgL6fILG9jHSnzmDGNaHUph/kjKX+rnNnLIzuBeuKT/RO5f1BP WHJkUA3ujDoyHeZ74s50Utf6HjKtCzCUrCMDLkrV/rWhC7H8510231fWhi4X9434+KToATFkeL1w emeIu0pUCzNkZ5sXPa81ns9+8FTttg+RTC3EH4KaLcTvLP27qNnC/NaNaidQPeRLLy295am3Xmc8 n9SQxx+uFrYwn6YWtsrxO6uFO7WQEy4oG38docI1tzBOvVlwCJxq2wU2Whq7Oa29nO2ujCKPCDz1 Vu4JIEoRChuNfL4mFPY9n9nMAcFhVm8P5YcNQp515RtHW1WQCSGO0JqK++1NT62v/8AhWcfA3PKp P8kDE7kIT62vv8h9UCM/esGZ+JLCxiX8KmtOPPXXzezCvb7xhwNHnzkDc4StgWvNrgeWeTW7vvZd fahf/d04cXvFeVt+QAgbMYY5TimcyvHS2BL8XT3nqY1BAT/fLgDYTezu0NYvLUMf+CPdGJg2cgaO PbIGvmUMr21zdmP5VgO7deC5nK4ZRnHCJ8FbY0FiTElSxaqKUHMWggTD/zFCqyKh1aev0/8AAAD/ /wMAUEsDBBQABgAIAAAAIQDtg903yQIAAK4IAAAUAAAAeGwvc2hhcmVkU3RyaW5ncy54bWyUVstu 2zAQvBfoPxA6tUBsyW5SFIHtgI0YmdHLICXdiYi1VduSa8lGes9n5JhvyMk3/VjJOEFbUkqUk83l zszuEORqdHG7XoE935ZZkY+NQd8yAM9vijTL52Mjjq563wxQVixP2arI+dj4zUvjYvLxw6gsKyCw eTk2FlW1OTfN8mbB16zsFxuei50fxXbNKrHczs1ys+UsLRecV+uVObSsr+aaZbkBbopdXgld69QA uzz7teOXx8jZqTEZldlkVE1gdAmWRZGOzGoyMmXsGLdntjmwLMusH+vHTf3A96wEQ2t42jXxrCGx l3IhNt+x7b6NS0nRWNz6IdvzRvTfLQ3l14f6sAT1YZWyTcX5Mkv5ioNPyye2z410HTCddTZsyfM0 S9+n9B+qTWvBsvmKvber11Hv0OrUWYNap94qnpWVPChW7qrd8W+XM3sL19ZfI65Th28jNU2oXhCK kI3c2HM8CK4hgDhACZyiKKZq5nc1kCCCJUb8Ii8MfRQSBwbYVvMu1YALiY3DBFKhCyGh9T2NEPK1 u6sFEPFhFAotB0MKXEjjCEYwgfZT3ZqwoxLEJHRQgCMIvRdR2QCNnXgaEj8MG6qfao49l0uRDZ5R M4JmkEBoY/sEJH2FUUrggMYexg381yo/Dq6QG1EsqxEeRVAKyXOxwUvRFLkv7ftYLlQOT7ecJvBa WPXMJ0vy/TgI/dCOPSROstVF7VyoizwU4Z6Hp5C2HV6gVhDUdyTBbekzNV36STG2FQtOpJPCHiwM Epu29FaYjzwPBWKpshA1MMWBA4VnbXVoTvpINIu8uIk90W4EJFi7YQRFFM0iTGCCfb1Et76j2K/v 63unLYXUh8WagTxbc/EgaU7xbSZm6TmwxKwf9OW4BD3wZdAfDOXitXHRAz8Z0N/JXHwqgIbHRVM+ DphKPJUts3WmZvxTjSm+NyZ/AAAA//8DAFBLAwQUAAYACAAAACEAu0sn4kkBAABvAgAAEQAIAWRv Y1Byb3BzL2NvcmUueG1sIKIEASigAAEAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAjJJfT8Mg FMXfTfwOhPcW2sVtIW0X/2QPxiVGZzS+EbjbGgslgHb79tJ2qzXzwUc45/4454ZssVcV+gLrylrn OIkpRqBFLUu9zfHLehnNMXKea8mrWkOOD+Dwori8yIRhorbwaGsD1pfgUCBpx4TJ8c57wwhxYgeK uzg4dBA3tVXch6PdEsPFB98CSSmdEgWeS+45aYGRGYj4iJRiQJpPW3UAKQhUoEB7R5I4IT9eD1a5 Pwc6ZeRUpT+Y0OkYd8yWohcH996Vg7FpmriZdDFC/oS8rR6eu6pRqdtdCcBFJgUTFrivbXHPtQb0 DMagCD1dZ2SktXusuPOrsPJNCfLmcG4/twR6V6Z/AiQK8Vhf5qS8Tm7v1ktcpDSdRgmNknRNZ2wy Y1ez9zbBr/k2bn+hjjn+SZwzSlmSjognQJGRsy9SfAMAAP//AwBQSwMEFAAGAAgAAAAhAPwGu+OQ AQAAEgMAABAACAFkb2NQcm9wcy9hcHAueG1sIKIEASigAAEAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAnJJNbtswEIX3BXoHgfuYclIEhUExCJwUWbSoASvZT6mRRZQiBXIs2D1YLpCLdSQhjpx0 1d38PDx+fKS6ObQu6zEmG3whlotcZOhNqKzfFeKx/HbxVWSJwFfggsdCHDGJG/35k9rE0GEkiylj C58K0RB1KymTabCFtOC1500dYgvEbdzJUNfW4F0w+xY9ycs8v5Z4IPQVVhfdyVBMjque/te0Cmbg S0/lsWNgrW67zlkDxLfUP6yJIYWasvuDQafkfKmYbotmHy0dda7kvFVbAw7XbKxrcAmVfBuoB4Qh tA3YmLTqadWjoRCzZP9wbJci+wUJB5xC9BAteGKsQTY1Y+26RFGXL88vzw4brJRkwTQcy7l2Xtsv ejkKuDgXDgYTCC/OEUtLDtPPegOR/kG8nBOPDBPvhHMb9+A9J/AOcLwzH/XOfB3aDvyRF6fqu/W/ 02NXhjsgfM3zfKi2DUSs+AlOeZ8G6oGjjG4wWTfgd1i9aj4uhtd/mr64Xl4v8qucH3Y2U/LtM+u/ AAAA//8DAFBLAwQUAAYACAAAACEAULFoi8wBAACWBgAAEwAIAWRvY1Byb3BzL2N1c3RvbS54bWwg ogQBKKAAAQAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAA AAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAC0lV1r2zAYhe8H+w9G11X9SpY/FJKU 5qNQWEch2S52E2TrdWKIJWMr2cLof5+ytQsZDIaHbwRC5ug5h9dH47tv9T44YttV1kwIuwUSoCms rsx2Qj6tH2hGgs4po9XeGpyQE3bkbvr+3fi5tQ22rsIu8BKmm5Cdc80oDLtih7Xqbv2x8SelbWvl /LbdhrYsqwIXtjjUaFzIAZKwOHTO1rT5LUd+6Y2Orq+ktsWZrvu8PjUedzp+FT8FZe0qPSHfF/F8 sYghpnwp55QBm1EZyZRCBsBnfP4g75cvJGjOH3MSGFV760+rx+fNB5XjfqOxVIKlQEEzSQG8kl8E zYssS5mIRKz5ZmlUvkft7z+60b752rl26toDjsPLfhy+sf0nZdSXcoVuoRxeUXLgiU+FMr6GdCTY SIgvg1CLvtRP6Hb2OtrVzylt9SCgcV/Qj350rrL9l9EZxELSe0Iqh4/XWWclgsw0p4JnmopcCyoz iGjKZFyiTEpAPoiJtK+J+8L5hvvDhooBc9SF54acCp0zKiXLaRKLIpcqzuJomL/Vl2q/Tplb43x1 zip37rVLj8Agacu+mGu1vcJjcBNEN4Ff2d9Aw8uDMv0BAAD//wMAUEsBAi0AFAAGAAgAAAAhAKcM 63loAQAADQUAABMAAAAAAAAAAAAAAAAAAAAAAFtDb250ZW50X1R5cGVzXS54bWxQSwECLQAUAAYA CAAAACEAE16+ZQIBAADfAgAACwAAAAAAAAAAAAAAAAChAwAAX3JlbHMvLnJlbHNQSwECLQAUAAYA CAAAACEAq0c/7/QDAAC4CQAADwAAAAAAAAAAAAAAAADUBgAAeGwvd29ya2Jvb2sueG1sUEsBAi0A FAAGAAgAAAAhAIE+lJfzAAAAugIAABoAAAAAAAAAAAAAAAAA9QoAAHhsL19yZWxzL3dvcmtib29r LnhtbC5yZWxzUEsBAi0AFAAGAAgAAAAhAJdHzenPHAAAOXAAABgAAAAAAAAAAAAAAAAAKA0AAHhs L3dvcmtzaGVldHMvc2hlZXQxLnhtbFBLAQItABQABgAIAAAAIQC7WB9rxQcAABYiAAATAAAAAAAA AAAAAAAAAC0qAAB4bC90aGVtZS90aGVtZTEueG1sUEsBAi0AFAAGAAgAAAAhAKz2YZ/tBAAAwx0A AA0AAAAAAAAAAAAAAAAAIzIAAHhsL3N0eWxlcy54bWxQSwECLQAUAAYACAAAACEA7YPdN8kCAACu CAAAFAAAAAAAAAAAAAAAAAA7NwAAeGwvc2hhcmVkU3RyaW5ncy54bWxQSwECLQAUAAYACAAAACEA u0sn4kkBAABvAgAAEQAAAAAAAAAAAAAAAAA2OgAAZG9jUHJvcHMvY29yZS54bWxQSwECLQAUAAYA CAAAACEA/Aa745ABAAASAwAAEAAAAAAAAAAAAAAAAAC2PAAAZG9jUHJvcHMvYXBwLnhtbFBLAQIt ABQABgAIAAAAIQBQsWiLzAEAAJYGAAATAAAAAAAAAAAAAAAAAHw/AABkb2NQcm9wcy9jdXN0b20u eG1sUEsFBgAAAAALAAsAwQIAAIFCAAAAAA== ------=_NextPart_000_0235_01DD5CA3.8EC8C590--